← Open Payments lookup

LENNART MOLLER: Open Payments

NPI 1336224237 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$367 in 10 payments from 7 companies in 2025. Trend: 2023 $939 · 2024 $590 · 2025 $367

Food & beverage: $367
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$139
Janssen Pharmaceuticals, Inc3$69
Teva Pharmaceuticals USA, Inc.2$60
E.R. Squibb & Sons, L.L.C.1$28
Otsuka America Pharmaceutical, Inc.1$28
Alkermes, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21

Products named: INGREZZA, INVEGA SUSTENNA, UZEDY, COBENFY, REXULTI, ARISTADA, CAPLYTA.

Industry payments across CA — which companies pay providers there.